ALDX
Aldeyra Therapeutics, Inc.
- Latest sale
- $114k
- Aug 11 · No plan
- Form 4 sales
- 9
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planOct 18 2023
Sold 2.8M shares at $1.62 ($4.5M)
Perceptive Life Sciences Master Fund Ltd, 10% owner
No 10b5-1 planSold 24.3% of holdings ($18.3M position)8.6M shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planMar 11 +145 days
Sold 13,201 shares at $3.41 ($45k)
Greenberg Bruce, Officer
No 10b5-1 planSold 9.9% of holdings ($457k position)120,699 shares leftFirst sale on recordFiling
- 3 Form 4 saleNo planMar 12 +1 day
Sold 183,238 shares at $3.17 ($580k)
Brady Todd C, President and CEO
No 10b5-1 planSold 11.1% of holdings ($5.2M position)1.5M shares leftFirst sale on recordFiling
- 4 Form 4 saleNo planMar 12 same day
Sold 29,768 shares at $3.31 ($99k)
Machatha Stephen, Chief Development Officer
No 10b5-1 planSold 10.9% of holdings ($905k position)243,495 shares leftFirst sale on recordFiling
- 5 Form 4 saleNo planAug 12 +153 days
Sold 10,834 shares at $4.74 ($51k)
Greenberg Bruce, Officer
No 10b5-1 planSold 7.9% of holdings ($650k position)126,382 shares leftFiling
- 6 Form 4 saleNo planAug 12 same day
Sold 16,041 shares at $4.74 ($76k)
Machatha Stephen, Chief Development Officer
No 10b5-1 planSold 6.3% of holdings ($1.2M position)236,771 shares leftFiling
- 7 Form 4 saleUnusualApr 3 +234 days
Sold 3.4M shares at $1.42 ($4.8M)
Perceptive Life Sciences Master Fund Ltd, 10% owner
No 10b5-1 planSold 36.7% of holdings ($13.2M position)5.9M shares leftFiling
- 8 Form 4 saleNo planAug 11 +130 days
Sold 22,073 shares at $5.15 ($114k)
Machatha Stephen, Chief Development Officer
No 10b5-1 planSold 9.1% of holdings ($1.3M position)221,799 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (9)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Machatha Stephen | Chief Development Officer | Form 4 sale | 22,073 | $114k | 9.1% | No plan | SEC |
| Apr 3, 2025 | Perceptive Life Sciences Master Fund Ltd | 10% owner | Form 4 sale | 3.4M | $4.8M | 36.7% | Unusual | SEC |
| Aug 12, 2024 | Machatha Stephen | Chief Development Officer | Form 4 sale | 16,041 | $76k | 6.3% | No plan | SEC |
| Aug 12, 2024 | Greenberg Bruce | Officer | Form 4 sale | 10,834 | $51k | 7.9% | No plan | SEC |
| Mar 12, 2024 | Machatha Stephen | Chief Development Officer | Form 4 sale | 29,768 | $99k | 10.9% | No plan | SEC |
| Mar 12, 2024 | Brady Todd C | President and CEO | Form 4 sale | 183,238 | $580k | 11.1% | No plan | SEC |
| Mar 11, 2024 | Greenberg Bruce | Officer | Form 4 sale | 13,201 | $45k | 9.9% | No plan | SEC |
| Oct 18, 2023 | Perceptive Life Sciences Master Fund Ltd | 10% owner | Form 4 sale | 2.8M | $4.5M | 24.3% | No plan | SEC |
| Mar 26, 2019 | Treu Jesse I | Director | Form 4 sale | 96,743 | $968k | 91.7% | Unusual | SEC |